PDE3B and fatty liver disease: In this study, we present clear data supporting the function of PDE3B inhibition in raising energy expenditure by promoting WAT browning and highlight the possible therapeutic effects of cilostazol on obesity and obesity-related complications, such as hepatic steatosis.